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A major obstacle thwarting preclinical development of microbicides is the lack 27 of a validated biomarker of cervicovaginal inflammation. Therefore, the present study 28 aims to identify novel noninvasive soluble markers in a murine model for assessment 29 of microbicide mucosal safety. By performing cytokine antibody array analysis, we 30 identified two adhesion molecules, L-selectin and P-selectin, which significantly 31 increased when mucosal inflammation was triggered by Nonoxynol-9 (N9)，the 32 clinical trial-failed anti-HIV-1 microbicide candidate, in a refined murine model of 33 agent-induced cervicovaginal inflammation. We found that L-selectin and P-selectin 34 had obviously different patterns of detection than the two previously defined 35 biomarkers of cervicovaginal inflammation, monocyte chemotactic protein 1 (MCP-1) 36 and interleukine 6 (IL-6). These two soluble selectins correlated better than MCP-1 37 and IL-6 with the duration and severity of mucosal inflammation triggered by N9 and 
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In constructing a safety profile, much can be learned from the N9 story. First, 73 microbicidal efficacy depends on striking a balance between specific activity and 74 safety, and the absence of inflammatory events is a key issue for microbicidal safety. 75 Second, colposcopic evaluation is an unreliable predictor of local inflammation. 76 Finally, inflammation resulting from exposure to N9 has been detected by different 77 methods, including histology, neutrophil count, and cytokine-chemokine release (18). 78 Although histology analysis could enable investigators to identify inflammation, it 79 would also require biopsy specimens of vaginal or cervical tissue taken shortly before 80 and after exposure to the test agent. In addition, this method is qualitative and not 81 sensitive enough to determine mucosal inflammation without obvious tissue damage. Therefore, we first analyzed the kinetics of MCP-1. MCP-1 peaked at 4 hr (p<0.001) 240 and then declined sharply at later time points (Fig. 1) . Therefore, we collected CVL 4 Conversely, dilation could be seen in all tissues, but it was more obvious in tissues 285 from N9-treated mice (Table 1) .
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To verify the histological changes and further elucidate the quality and quantity As shown in Fig. 3B and Fig. 1 , proinflammatory cytokine IL-6 and chemokine 301 MCP-1 in CVL increased only transiently, with a peak at the 2-and 4-hr time points (Fig. 4B) .
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Compared to zero dose (PBS only), a dose of 40 mg/ml N9 was sufficient to 324 induce significant increases of MCP-1 and IL-6, while 8 mg/ml N9 could increase 325 mild, but not significant, expression of MCP-1 and IL-6 (Fig. 4C, D) . However, the 8 326 mg/ml N9 dose induced significant increase of L-and P-selectin (Fig. 4E, F Furthermore, as shown in Figure 5D , former is more resistant and the latter is more sensitive to irritation of N9 and other 514 proinflammatory agents. Our study also agreed with other two previous studies (9, 16).
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Despite of some discrepancy, our study and Catalone's study also had some 
